Paper40361900
Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review.
Chatzikostopoulos A and 3 others. Diagnostics (Basel), 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review. Papers, record 40361900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40361900
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34645914 | Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression. | Sci Rep | 2021 | https://conductscience.org/library/papers/34645914 | PubMed |
| 2 | 32909371 | Genetics of neuropsychiatric symptoms in patients with Alzheimer's disease: A 1-year follow-up study. | Psychiatry Clin Neurosci | 2020 | https://conductscience.org/library/papers/32909371 | PubMed |
| 3 | 34814099 | Interactions of comorbid neuropsychiatric subsyndromes with neurodegenerative and cerebrovascular pathologies on cognition. | Neurobiol Aging | 2022 | https://conductscience.org/library/papers/34814099 | PubMed |
| 4 | 29527163 | When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression. | Front Aging Neurosci | 2018 | https://conductscience.org/library/papers/29527163 | PubMed |
| 5 | 36647262 | Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease. | Hum Brain Mapp | 2023 | https://conductscience.org/library/papers/36647262 | PubMed |
| 6 | 21073721 | Unmet needs, quality of life and support networks of people with dementia living at home. | Health Qual Life Outcomes | 2010 | https://conductscience.org/library/papers/21073721 | PubMed |
| 7 | 32088096 | The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum. | Am J Geriatr Psychiatry | 2020 | https://conductscience.org/library/papers/32088096 | PubMed |
| 8 | 29653606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 9 | 35346458 | Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline. | Biol Psychiatry | 2022 | https://conductscience.org/library/papers/35346458 | PubMed |
| 10 | 37840496 | Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37840496 | PubMed |
| 11 | 39254167 | Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline. | Hum Brain Mapp | 2024 | https://conductscience.org/library/papers/39254167 | PubMed |
| 12 | 36909142 | Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline. | Psychiatr Res Clin Pract | 2023 | https://conductscience.org/library/papers/36909142 | PubMed |
| 13 | 39372373 | Linking cognitive and behavioral reserve: Evidence from the CAN-PROTECT study. | Alzheimers Dement (N Y) | 2024 | https://conductscience.org/library/papers/39372373 | PubMed |
| 14 | 37516848 | Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO. | Mol Neurodegener | 2023 | https://conductscience.org/library/papers/37516848 | PubMed |
| 15 | 37544835 | Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment. | Am J Geriatr Psychiatry | 2023 | https://conductscience.org/library/papers/37544835 | PubMed |
| 16 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 17 | 28011140 | Learning Their Language: The Importance of Detecting and Managing Pain in Dementia. | Am J Geriatr Psychiatry | 2017 | https://conductscience.org/library/papers/28011140 | PubMed |
| 18 | 30998118 | Personality and the risk factors for developing behavioral and psychological symptoms of dementia: a narrative review. | Neurodegener Dis Manag | 2019 | https://conductscience.org/library/papers/30998118 | PubMed |
| 19 | 36323521 | Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease. | Neurology | 2023 | https://conductscience.org/library/papers/36323521 | PubMed |
| 20 | 31424398 | Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review. | J Alzheimers Dis | 2019 | https://conductscience.org/library/papers/31424398 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978812 | Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42978812 | PubMed |
| 42277629 | Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42277629 | PubMed |
| 41874039 | First Analysis of Mild Behavioral Impairment in a Sample of Mexican Older Adults. | NeuroSci | 2026 | https://conductscience.org/library/papers/41874039 | PubMed |
| 41226107 | Sleep Trajectories in Amnestic and Non-Amnestic MCI: Longitudinal Insights from Subjective and Objective Assessments. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41226107 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40361900
GET https://conductscience.org/api/papers/v1/40361900/references?page=2